Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukaemia (Acute)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00469859
What this trial is testing

Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 14
Large-scale testing (Phase 3)Active Not RecruitingNCT04229979
What this trial is testing

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

Who this might be right for
Acute Myeloid Leukemia
Sellas Life Sciences Group 127
Testing effectiveness (Phase 2)Study completedNCT01930162
What this trial is testing

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant

Who this might be right for
Single Umbilical Cord Blood TransplantationNon-myeloablative ConditioningAcute Lymphocytic Leukemia+4 more
Novartis Pharmaceuticals 9
Testing effectiveness (Phase 2)Study completedNCT00096096
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Very early researchStudy completedNCT05907603
What this trial is testing

Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)

Who this might be right for
NeoplasmsHematologic NeoplasmsHematologic Diseases
Kai Lin Xu，MD 8
Testing effectiveness (Phase 2)Looking for participantsNCT06034561
What this trial is testing

Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed Remission
Instituto do Cancer do Estado de São Paulo 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05356169
What this trial is testing

Intensive Therapy Combined With Venetoclax for Adult Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 312
Testing effectiveness (Phase 2)Study completedNCT00005962
What this trial is testing

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT02473146
What this trial is testing

Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4

Who this might be right for
Acute Myeloid Leukemia
Versailles Hospital 225
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07443488
What this trial is testing

Efficacy and Safety of Olverembatinib Plus Inotuzumab Ozogamicin as First-Line Consolidation Therapy Followed by HSCT in Ph+ ALL

Who this might be right for
HSCTPh+ ALL
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT00489203
What this trial is testing

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more
Fred Hutchinson Cancer Center 140
Testing effectiveness (Phase 2)WithdrawnNCT05909527
What this trial is testing

A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma

Who this might be right for
T-Cell Acute Lymphocytic Leukemia
Guangzhou Bio-gene Technology Co., Ltd
Testing effectiveness (Phase 2)Study completedNCT00391014
What this trial is testing

Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Haematopoietic Progenitor Cell Transplant
PETHEMA Foundation 150
Testing effectiveness (Phase 2)Looking for participantsNCT05360160
What this trial is testing

A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)

Who this might be right for
Acute Myeloid Leukemia
M.D. Anderson Cancer Center 43
Testing effectiveness (Phase 2)Ended earlyNCT02992860
What this trial is testing

Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY

Who this might be right for
Myelodysplastic Syndrome (MDS)Acute Myeloid Leukemia (AML)
GWT-TUD GmbH 25
Large-scale testing (Phase 3)Study completedNCT00248443
What this trial is testing

Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage

Who this might be right for
LymphomaCancerAcute Respiratory Failure+1 more
Assistance Publique - Hôpitaux de Paris 206
Early research (Phase 1)WithdrawnNCT03705858
What this trial is testing

Actinium-225-Lintuzumab in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Joseph Jurcic
Not applicableLooking for participantsNCT05587049
What this trial is testing

Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Oral Venetoclax Tablets in Combination With Subcutaneously (SC) or Intravenously (IV) Injected Azacitidine in Colombia

Who this might be right for
Acute Myeloid Leukemia
AbbVie 70
Early research (Phase 1)Ended earlyNCT05817058
What this trial is testing

First-in-Human Dose Escalation Study of AFM28 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Affimed GmbH 30
Testing effectiveness (Phase 2)Study completedNCT00003148
What this trial is testing

Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 86
Next Page